Shares in cancer diagnostic company Pacific Edge have risen 10% or 3c to 32c in today’s trading after the company advised notification of a national reimbursement rate for its CX bladder tests on patients covered under the Centers for Medicare and Medicaid Services (CMS), the largest medicare
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
